Dr. Peter McCullough's Spike Protein Detox Protocol: Base Spike Detox Explained
1. What Is the Base Spike Detox?
The Base Spike Detox is a clinical protocol developed by Dr. Peter McCullough — internist, cardiologist, and one of the most-published physicians in the United States — designed to help the body degrade and clear persistent SARS-CoV-2 spike protein.
In a widely shared post on X (formerly Twitter), Dr. McCullough explained the rationale:
"Base Spike Detox is what I am currently using in my practice for those who have had COVID-19 multiple times, one or more of the COVID-19 vaccines, or both, and believe persistent SARS-CoV-2 Spike protein could be causing problems in their body. I have arrived, based on the emerging scientific literature and my clinical observation, that three OTC products are essential as a triple base combination." — Dr. Peter McCullough, MD, MPHThe protocol targets a specific problem: spike protein — introduced by either natural SARS-CoV-2 infection or mRNA vaccination — appears to persist in some individuals, potentially driving ongoing inflammation, clotting abnormalities, and immune dysregulation associated with long COVID and post-vaccine syndromes.

2. Protocol: Ingredients, Doses & Timing
Base Spike Detox — Core Triple Combination
All three ingredients are over-the-counter. Minimum duration: 3 months. See Section 3 for full duration guidance.
-
1Nattokinase2,000 FU (100 mg) — twice daily ⚠ Take on an empty stomach. Do not take with anticoagulants without physician guidance.
-
2Bromelain500 mg — once daily ⚠ Take on an empty stomach. Avoid if allergic to pineapple or latex.
-
3Nano / Liposomal Curcumin500 mg — twice daily ✓ Take with food. Nano or liposomal form required for adequate absorption.
Quick-Reference Dosing Table
- Nattokinase: 2000 FU (100 mg) twice daily (on an empty stomach).
- Bromelain: 500 mg once daily (on an empty stomach).
- Curcumin (preferably nano or liposomal form for better absorption): 500 mg twice daily (with food).
3. How Long Should You Take the Base Spike Detox?
This is the most frequently asked question about the protocol. Dr. McCullough's guidance, drawn from his 2023 Cureus publication and subsequent clinical updates, is as follows:
- Minimum duration: 3 months
- Typical duration: 6–12 months, depending on symptom burden and laboratory response
- Severe or persistent cases: More than one year may be required
- Ongoing use: If well tolerated, the protocol can be continued indefinitely to prevent recurrence from reinfection or re-exposure
"Don't expect instant results, be patient. Three months is a minimum duration, and some require more than a year." — Dr. Peter McCullough
Progress can be tracked objectively using spike protein antibody testing (see Section 6). Symptom improvement is the primary clinical endpoint when testing is unavailable.
4. The Science Behind Each Ingredient
Nattokinase: Direct Spike Protein Degradation
Nattokinase is a serine protease derived from fermented soybeans (natto). It is best known as a fibrinolytic — an enzyme that breaks down fibrin clots — and has over 250 published studies on PubMed.
In a 2022 study, Tanikawa and colleagues demonstrated that nattokinase degrades the SARS-CoV-2 spike protein in a time- and dose-dependent manner, both in cell lysate preparations (analogous to the environment in a vaccine recipient) and in SARS-CoV-2-infected cells.4 This was independently reproduced by Oba and colleagues.
In human pharmacokinetic studies, Kurosawa et al. found that a single oral dose of 2,000 FU significantly elevated D-dimer at six and eight hours post-administration and elevated fibrin/fibrinogen degradation products at four hours — confirming meaningful systemic fibrinolytic activity after oral intake.
Bromelain: Fragment Clearance & Anti-Inflammation
Bromelain is a mixture of proteolytic enzymes derived from pineapple (Ananas comosus). It has well-documented anti-inflammatory, fibrinolytic, and mucolytic properties. In the context of spike protein pathology, bromelain is hypothesized to assist in degrading spike protein fragments that nattokinase leaves behind, while simultaneously reducing the systemic inflammation those fragments provoke.
Bromelain also prolongs prothrombin time, contributing to the protocol's overall anticoagulant effect — which is relevant to its potential benefit in patients with spike-induced microclotting.
Curcumin (Nano/Liposomal): Inflammation Reduction & Immune Modulation
Curcumin, the active polyphenol in turmeric, has potent NF-κB inhibitory and antioxidant properties. Standard curcumin has poor bioavailability; nano- or liposomal formulations are essential to achieve the tissue concentrations needed for meaningful anti-inflammatory effect.
In the context of this protocol, curcumin complements nattokinase and bromelain by addressing the downstream inflammatory cascade triggered by circulating spike protein and its fragments.
Ivermectin: Reversing Spike-Induced Hemagglutination
Former NIH researcher David Scheim, PhD, proposed early in the pandemic that SARS-CoV-2 spike protein acts like a grappling hook, pulling circulating red blood cells (RBCs) into chains and clumps — a process called hemagglutination (HA) — impairing oxygen delivery and contributing to microclotting in the lungs.
Boschi et al.6 subsequently demonstrated that ivermectin reverses this effect:
"Ivermectin blocked hemagglutination when added to RBCs prior to spike protein and reversed HA when added afterwards."
Stone et al.7 documented a 62% normalization in oxygen saturation within 24 hours of ivermectin-based combination treatment in severe COVID-19 patients — a rate of improvement that, given its speed, points to a direct anti-spike protein mechanism rather than an antiviral effect alone.
5. Add-On Agents: Beyond the Base Combination
Dr. McCullough notes that additional agents can be incorporated based on a clinical evaluation and the specific syndrome present. These are not universally recommended and generally require physician prescription and oversight:
- N-acetylcysteine (NAC) for further detoxification.
- Ivermectin (prescription) for reversing spike-induced blood clumping.
- Others like hydroxychloroquine, low-dose naltrexone, or blood thinners if specific risks (e.g., clotting) are present.
6. How to Monitor Your Progress
Dr. McCullough recommends objective laboratory monitoring to guide treatment duration and assess response:
Spike Protein Antibody Testing
The Labcorp Semi-Quantitative Spike Protein Antibody Test (available in most US states directly through Labcorp's website without a physician order) can establish a baseline level of spike protein antibody and track reductions over time. Several patients have documented marked reductions — for example, Dr. Robert Enzenauer reported his spike antibody falling from 1:25,000 to 1:740 over six months on the protocol.
Healthlabs.com also offers a COVID-19 antibody test that can be ordered online and completed at a local lab.
Symptom Tracking
In the absence of laboratory testing, symptom improvement is the primary marker. Common targets include: resolution of fatigue, brain fog, exercise intolerance, dyspnea, and musculoskeletal pain.
Coagulation Monitoring
Given the significant fibrinolytic and anticoagulant activity of this combination, patients and clinicians should monitor for:
- Easy bruising
- Nasal mucosal bleeding
- Gastrointestinal bleeding symptoms
- Prolonged bleeding from minor cuts
These are signals to reduce the dose or temporarily suspend the protocol, with physician guidance.
7. Safety Warnings & Contraindications
🚫 Absolute Contraindications
- Active bleeding disorder (e.g., hemophilia)
- Pregnancy (without physician direction)
- Breastfeeding (without physician direction)
- Known soy allergy (nattokinase)
- Known pineapple or latex allergy (bromelain)
- Children under 18 (without physician direction)
⚠️ Use with Caution / Physician Oversight Required
- Concurrent anticoagulants (warfarin, apixaban, rivaroxaban, dabigatran)
- Concurrent antiplatelet drugs (aspirin, clopidogrel)
- History of GI bleeding or peptic ulcer disease
- Women of childbearing potential without contraception
- Gastrointestinal intolerance or sensitivity
Using the Protocol with Anticoagulants
This is among the most common patient questions. Dr. McCullough addressed it directly in 2025:
"As an internist and cardiologist, the answer is yes [it can be used with anticoagulants], but this must be done with doctor's guidance. Nattokinase is an oral thrombolytic. Bromelain is an anticoagulant that prolongs prothrombin time... On anticoagulants? Bring your doctors in the loop." — Dr. Peter McCullough, X/Twitter, 2025
In clinical practice, Dr. McCullough has used full-dose Ultimate Spike Detox alongside apixaban, rivaroxaban, dabigatran, and warfarin in patients with thrombotic complications. The primary safety signal is bleeding — excessive mucosal bleeding or unusual bruising indicates a dose reduction of either the detox supplement or the anticoagulant, per physician judgment.
8. Clinical Observations & Patient Stories
Dr. Robert W. Enzenauer, MD, MPH (Physician, September 2024)
Dr. Bruce Boros, MD (Internist & Cardiologist, Florida Keys)
Dr. Boros, age 75 and unvaccinated, developed symptoms consistent with long-COVID syndrome — loss of mental clarity, cognitive fog, and profound fatigue — that threatened his active medical practice. After discussing the science of the McCullough protocol, he initiated Ultimate Spike Detox from The Wellness Company. Built on a prior regimen that included ivermectin for acute COVID treatment, Dr. Boros reported resolution of his symptoms within weeks, with similar improvements observed in his long-COVID patients.
Dr. McCullough notes that a detoxification protocol should be followed for at least one year to prevent symptom recurrence, which may occur with reinfection or re-exposure. If well tolerated, these products can be continued indefinitely.
Patient: Taste and Smell Restoration (Long COVID, March 2025)
Patient: Leg Swelling Resolution (Vaccine Injury, February 2025)
Patient: Blood Clot in the Eye (Nurse, November 2024)
Long COVID: Leg Swelling with Protocol + Ivermectin (September 2025)
9. COVID-19 Vaccine Myocarditis Research
Dr. Peter McCullough co-authored a study on vaccine-induced myocarditis that was awarded first place on Preprints.org in the Medicine and Pharmacology category (Cardiac & Cardiovascular Systems) for 2023.
The paper — Autopsy Proven Fatal COVID-19 Vaccine-Induced Myocarditis3 — examined fatal outcomes of myocarditis following COVID-19 vaccination, providing histopathological evidence from autopsy cases. It was subsequently published in the European Journal of Heart Failure.
This body of research forms part of the broader scientific context motivating the development of post-vaccine syndrome management protocols, including the Base Spike Detox.
10. Frequently Asked Questions
Find a Physician Familiar with This Protocol
The Wellness Company offers virtual consultations with physicians experienced in spike protein management, long COVID, and post-vaccine syndromes — available across the United States.
Book a Virtual ConsultationRelated Articles
References & Sources
- McCullough PA, et al. Clinical Approach to Post-acute Sequelae After COVID-19 Infection and Vaccination. Cureus. 2023 Nov 21. PubMed PMC10663976
- Preprints.org 2023 Most Popular Preprints Award. preprints.org
- Halma MTJ, Plothe C, Marik P, Lawrie TA. Strategies for the Management of Spike Protein-Related Pathology. Microorganisms. 2023;11(5):1308. Also: Autopsy findings in cases of fatal COVID-19 vaccine-induced myocarditis. Eur J Heart Fail. doi:10.1002/ehf2.14680
- Tanikawa T, Kiba Y, Yu J, et al. Degradative Effect of Nattokinase on Spike Protein of SARS-CoV-2. Molecules. 2022 Aug 24;27(17):5405. PMID 36080170
- Nattokinase on PubMed (250+ studies). pubmed.ncbi.nlm.nih.gov
- Boschi C, et al. SARS-CoV-2 spike protein and hemagglutination. Int J Mol Sci. 2022;23(24):15480. mdpi.com
- Stone S, et al. 62% Normalization in SpO2 within 24 Hours for severe COVID-19 patients after Ivermectin-Based Combination Treatment. Drugs Drug Candidates. 2023;2(3). mdpi.com
- McCullough PA. Profile in Valor: Internist and Cardiologist. Substack
We don't ask for blind trust — we ask you to read the evidence and exercise your own judgment in consultation with your physician. Our goal is to provide timely, accurate summaries of emerging clinical literature and practitioner experience for patients navigating long COVID and post-vaccine syndromes. Where evidence is limited, we say so. Where large trials are absent, we note it. We encourage you to read the primary sources linked above and to seek care from a physician you trust.
Comments
Post a Comment